Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis

This publication has 26 references indexed in Scilit:

• Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients
  American Journal of Kidney Diseases, 1996
• Diagnosis and Classification of Dyslipidemia in Renal Disease
  Blood Purification, 1996
• Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Effects of Three Treatment Modes on Plasma Lipids and Lipoproteins in Uraemic Patients
  Annals of Medicine, 1994
• Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels
  Kidney International, 1990
• Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration
  Kidney International, 1988
• Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
• Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis
  Atherosclerosis, 1987
• Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.
  Journal of Clinical Investigation, 1986
• Serum Lipids and Lipoproteins during Continuous Ambulatory Peritoneal Dialysis
  Acta Medica Scandinavica, 1986